Lessl M. et al. (2011) Drug
Discov Today,
16, 288-292
"Grants4Targets – an innovative approach to translate ideas from basic research into novel drugs"
Dr. Kallio, University of
Turku, Finland:

“This program is a fantastic opportunity to forward pre-
clinical target discovery and validation. It can serve as an important bridge funding or allow execution of a few critical assays.”
read more
Our company’s mission is to provide new treatment options for diseases with high unmet medical need.
We are committed to innovation and to translating ideas from basic research into novel drugs.
We are dedicated to fostering collaborations with excellent academic groups and start-ups.
We strive for pooling expertise on common research topics and joining forces for mutual benefit.

Bayer allocates grants for the exploration of attractive, novel drug targets and biomarkers in the fields of: We look forward to hearing about your innovative ideas! On the following pages you will find more information on this initiative and the submission process.

The annual submission deadlines are March 31 and August 31.
Partner Your Antibodies